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Abstract
Purpose After acute myocardial infarction (AMI), left
ventricular (LV) remodelling may occur despite successful
reperfusion. This study aimed to investigate by gated single
photon emission computed tomography (SPECT) the long-
term evolution of myocardial perfusion and LV function
after AMI and to identify the predictors of LV remodelling.
Methods Sixty-eight AMI patients successfully treated by
primary percutaneous coronary intervention underwent
99mTc-sestamibi gated SPECT at 1 month (baseline) and
over 6-month follow-up after the acute event. LV remod-
elling was defined as 20% increase in LV end-diastolic
volume at follow-up.
Results At baseline, patients with remodelling (n=14)
showed larger (infarct size 29.3±7.8%) and more trans-
mural (infarct severity 0.28±0.10) infarctions, and reduced
LV ejection fraction (35.4±5.6%), but similar LV volume
indexes, compared to patients without remodelling (n=54)
(infarct size 20.8±14.4%, p<0.05, infarct severity 0.40±
0.11, p<0.001, ejection fraction 44.5±9.2, p<0.001). At
stepwise multivariate regression analysis, infarct severity
showed the best predictive value for predicting LV
remodelling (F=5.54, p<0.05). Using the thresholds
identified by receiver-operating characteristic curve analy-
sis, infarct size and severity detected patients with remod-
elling with 75% accuracy and 95% negative predictive
value. Infarct resorption (defined as the defect size
difference between follow-up and baseline) was comparable
between patients with (−4.4±8.4%) and without remodel-
ling (−6.8±9.4%) (p=NS).
Conclusion Perfusion parameters assessed by gated SPECT
in the subacute phase after successfully treated AMI correlate
with changes in functional parameters at long-term follow-
up. Infarct severity is more effective than infarct size, but
both are helpful for predicting LV remodelling.
Keywords Acute myocardial infarction .Myocardial
perfusion . Left ventricular function . Ventricular
remodelling
Introduction
Left ventricular (LV) remodelling after an acute myocardial
infarction (AMI) is defined as the progressive dilatation and
change in shape, size and function of the left ventricle,
occurring even after an effective reperfusion therapy such
as thrombolysis or percutaneous coronary intervention
(PCI) [1]. It represents an important cause of heart failure
and is a predictor of mortality [2, 3]. Several factors have
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been demonstrated to influence the evolution of LV
volumes after AMI, among which there are size, location
and transmurality of the infarction, residual viability in the
infarct territory and patency of the infarct-related artery [4].
The relative role of these factors, however, is still unclear.
Previous perfusion single photon emission computed
tomography (SPECT) data showed that infarct size mea-
sured 1 week after AMI is predictive of LV remodelling [5].
Using gated SPECT, a progressive reduction in infarct size
was observed after primary PCI and was associated with a
favourable short-term evolution of LV function [6]. These
results have been confirmed also using cardiac magnetic
resonance imaging. Orn et al. [7] showed that only scar
size, but neither location nor transmurality, was the primary
determinant of long-term LV remodelling. Lund et al. [8]
identified an infarct size threshold of 24% as predictive of
LV remodelling; moreover, they found that patients with LV
remodelling had a greater infarct size reduction, i.e. larger
infarct resorption, than patients with preserved LV volumes.
In disagreement with these data, studies exploring func-
tional abnormalities by echocardiography [9, 10] or the
presence of Q waves on the electrocardiogram [11]
indicated that infarct transmurality and the presence of
residual viability in the infarct territory could be more
important than the infarct size in influencing LV remodel-
ling. The relation between infarct severity and LV func-
tional outcome was also confirmed in gated SPECT studies,
showing that infarct severity was more effective than infarct
size for predicting subsequent LV remodelling [12, 13].
The purpose of this study was to investigate the
evolution of perfusion and functional parameters using
gated SPECT acquired at 1 month and then over 6 months
after AMI in a group of patients successfully treated with
primary PCI in order to evaluate the relationship between
changes in myocardial perfusion and LV functional out-
come at long-term follow-up and the accuracy of baseline
perfusion and functional parameters for predicting LV
remodelling at follow-up.
Materials and methods
Patient population and study protocol
This study included 68 patients (57 men, mean age 59.7±
11.7 years, range 33–87) admitted to our institutions
because of their first AMI and submitted to successful
primary PCI, defined as Thrombolysis in Myocardial
Infarction trial flow grade 3 [14] and residual stenosis
of <30% of lumen diameter, within 6 h of symptom onset.
The diagnosis of AMI was based on the following criteria:
(1) chest pain lasting >30 min and (2) >0.1-mV ST segment
elevation in at least two contiguous electrocardiographic
leads. Prior AMI was excluded based on history, electro-
cardiogram and echocardiographic pattern. Other exclusion
criteria were cardiac disease other than coronary artery
disease and life-limiting noncardiac disease. Patients un-
derwent resting 99mTc-sestamibi gated SPECT at 1 month
(baseline) of index AMI (mean 19±14 days) and after a
follow-up of at least 6 months (mean 380±358 days,
minimum 180 days). The Ethics Committees of our
Institutions approved the protocol and all subjects provided
informed consent.
Gated SPECT
Baseline and follow-up gated SPECT were acquired 60 min
after injection at rest of 99mTc-sestamibi (740 MBq), using a
dual-head camera (SKYlight, Philips Medical Systems,
Milpitas, CA, USA or e.cam, Siemens Medical Systems,
Hoffman Estates, IL, USA) equipped with high-resolution
collimators. Acquisition protocol parameters were the
following: 180° rotation arc, 32 projections, 60 s/projection,
8 frames/heart cycle and 64×64 matrices. The studies were
reconstructed using filtered backprojection without attenu-
ation or scatter correction and realigned along the heart
axis. Perfusion defects at rest were quantified as percentage
of LV wall, with the defect threshold set at 60% of peak
uptake [15]. Infarct severity at rest was defined as the
lowest ratio of minimal to maximal counts in the short-axis
slices examined for infarct size evaluation [16, 17].
Therefore, the lower the infarct severity value the more
transmural is the infarction. The QGS algorithm (Cedars-
Sinai Medical Center, Los Angeles, CA, USA) was used to
measure LV end-diastolic volume (EDV), end-systolic
volume (ESV) and ejection fraction (EF) [18]. Volumetric
data were corrected for body surface area and expressed as
indexes (I). Remodelling was defined as an increase in
LVEDVI at follow-up≥20% of the baseline value [19].
Statistical analysis
Data are expressed as mean value±SD. The comparisons
between groups were performed with Student’s t test for
unpaired samples or the Mann-Whitney U test, as appro-
priate. The within-group comparisons were made with
Student’s t test for paired samples. The comparison of
proportion was made with Fisher’s exact test. Linear
regression analysis was used to investigate the possible
relationship between perfusion and function. Correlations
between the change in infarct size and the changes in
functional parameters were analysed using Pearson’s
correlation coefficient. Stepwise multivariate and binary
analyses including candidate predictive variables were
performed by logistic regression analysis in order to
identify independent predictors of LV remodelling.
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Receiver-operating characteristic (ROC) curve analysis was
used for the selection of the best cutoff value of gated SPECT
parameters significantly different between the two groups for
the prediction of LV remodelling. A p value <0.05 was
considered statistically significant.
Results
Demographic and clinical characteristics of the patient
population are summarized in Table 1. None of the patients
had cardiac events during the follow-up period. In the
overall study population, at follow-up gated SPECT there
was a reduction in the infarct size (from 22.6±13.7% to
16.3±12.2%, p<0.0001) and an improvement of the infarct
severity (from 0.38±0.12 to 0.42±0.14, p<0.0001). LVEF
showed a marginal but significant improvement (from
42.6±9.3% to 44.9±10.8%, p<0.05). There was a moderate
correlation between the change in infarct size and the
change in LVEF (r=−0.42, p<0.0001) and per cent changes
in LVEDVI (r=0.39, p<0.005) and LVESVI (r=0.26,
p<0.05) (Fig. 1).
Results in patients with and without remodelling
There were 14 patients in whom the EDVI increased over
the remodelling threshold and 54 patients without remod-
elling. As shown in Table 1, no significant differences were
observed in the main demographic and clinical character-
istics of the two groups of patients.
Baseline and follow-up gated SPECT data for patients
with and without remodelling are shown in Table 2. In
patients without remodelling, there was a significant
correlation between the change in infarct size and the
change in LVEF (r=−0.43, p<0.005) and the per cent
change in LVESVI (r=0.41, p<0.005), whilst the correla-
tion with per cent change in LVEDVI was just borderline
(r=0.27, p=0.05) (Fig. 1). In patients with LV remodelling,
there was no significant correlation between changes in
perfusion and in functional parameters.
At baseline, patients with remodelling had larger
(p<0.05) and more transmural (p<0.001) infarctions as
compared to patients without remodelling. Baseline LVEF
was significantly (p<0.001) reduced in patients with
remodelling, while LV volume indexes were not different
between the two groups. At follow-up, in the group with
remodelling, volumes increased significantly (p<0.001),
while infarct size, infarct severity and LVEF did not change
(Fig. 2). Conversely, in the group without remodelling there
was a significant decrease in infarct size and transmurality
(both p<0.001) that was accompanied by a significant
functional improvement with higher LVEF and smaller
volume indexes (all p<0.05) (Fig. 2). Accordingly, at
follow-up infarct size (p<0.005) and severity (p<0.0001)
and LVEF (p<0.0001) of the remodelling versus non-
remodelling patients became more significantly different
than at baseline and the volume indexes became signifi-
cantly larger (both p<0.0001). The infarct resorption
(defined as the defect size difference between follow-up
and baseline) was not different between patients with and
without remodelling (−4.4±8.4% and −6.8±9.4%, respec-
tively, p=NS) (Fig. 3).
Predictors of LV remodelling
According to stepwise multivariate regression analysis,
infarct severity was the only significant predictor of per
cent change in EDVI (F=5.54, p<0.05). Using stepwise
binary logistic regression analysis, baseline infarct severity,
LVEF and EDVI were identified as significant predictors of
LV remodelling, correctly classifying 85.3% of patients into
the two groups (p<0.05).
Table 1 Demographic data and clinical characteristics of the patient
population
All
patients
(n=68)
With
remodelling
(n=14)
Without
remodelling
(n=54)
Demographic data
Age (years) 59.7±11.7 63.8±10.4 58.6±11.9
Males, n (%) 57 (83.8) 12 (85.7) 45 (83.3)
Clinical history
Smokers, n (%) 17 (25.0) 4 (28.6) 13 (24.1)
Hypertension, n (%) 39 (57.4) 8 (57.1) 31 (57.4)
Diabetes, n (%) 13 (19.1) 1 (7.1) 12 (22.2)
Dyslipidaemia, n (%) 32 (47.1) 7 (50.0) 25 (46.3)
Infarct-related coronary artery
LAD, n (%) 41 (60.3) 9 (64.3) 32 (59.3)
CX, n (%) 9 (13.2) 1 (7.1) 8 (14.8)
RCA, n (%) 18 (26.5) 4 (28.6) 14 (25.9)
Medication at discharge
Aspirin, n (%) 55 (80.9) 12 (85.7) 43 (79.6)
Clopidogrel, n (%) 45 (66.2) 11 (78.6) 34 (63.0)
Beta-blockers, n (%) 52 (76.5) 10 (71.4) 42 (77.8)
Statins, n (%) 50 (73.5) 12 (85.7) 38 (70.4)
ACE inhibitors, n (%) 53 (77.9) 11 (78.6) 42 (77.8)
Calcium antagonists, n (%) 6 (8.8) 2 (14.3) 4 (7.4)
Gated SPECT
Baseline study time (days) 18.6±14.6 15.8±14.3 19.3±14.8
Follow-up study time
(days)
380.3±
358.2
380.5±
321.8
380.3±
369.9
All p values NS
LAD left anterior descending coronary artery, CX circumflex coronary
artery, RCA right coronary artery, ACE angiotensin-converting enzyme
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Results of ROC curve analysis of gated SPECT variables
are shown in Table 3. According to both infarct size and
severity cutoff values extracted from ROC curve analysis,
patients were divided into two risk groups. The first group
included 27 “high-risk” patients, with infarct size >22.3%
and infarct severity <0.36 at baseline. Within this group, 12
of 27 patients (44%) showed LV remodelling at follow-up.
The remaining 41 patients composed a “low-risk” group,
including patients with both infarct size <22.3% and
severity >0.36 (33 patients) or with one abnormal parameter
only (either infarct size, 5 patients, or severity, 3 patients).
Only 2 of 41 (5%) of these patients presented remodelling
at follow-up. By dividing the patients into these two risk
groups, the cutoff values of infarct size (22.3%) and infarct
severity (0.36), considered together, demonstrated 86%
sensitivity, 72% specificity, 44% positive predictive value,
95% negative predictive value and 75% accuracy for
predicting remodelling (Fig. 4).
Discussion
We observed that infarct size and severity assessed by
perfusion gated SPECT correlate with changes in LV
functional parameters at long-term follow-up and are able
to predict LV remodelling with clinically acceptable
accuracy. The main novel findings of this study are the
following: (1) among perfusion parameters, infarct severity
was the only significant predictor of LV remodelling
according to multivariate analysis and (2) infarct resorption
was comparable in patients with and without LV remodel-
ling, despite previous results with cardiac magnetic reso-
nance imaging reporting greater infarct resorption in
patients with remodelling [8].
The extent of infarct size in patients treated with primary
PCI has been extensively used not only to confirm the
success of revascularization [20, 21], but also as a strong
prognostic predictor [22, 23]. This study confirms that in
patients submitted to successful PCI a spontaneous reduc-
tion in infarct size occurs beyond the 1-month evaluation.
These findings are in agreement with previous studies
reporting a significant late reduction in defect size in paired
sestamibi SPECT studies performed early and a few months
after AMI in patients treated conservatively or by throm-
bolysis [6, 24, 25]. Various mechanisms might play a role
in this delayed perfusion improvement. The presence of
Fig. 1 Correlation between infarct size change and a change in LVEF
(r=−0.42, p<0.0001), b per cent change in LVEDVI (r=0.39, p<
0.005) and c per cent change in LVESVI (r=0.26, p<0.05) in all
patients (solid line). White dots indicate patients without LV
remodelling and black dots patients with LV remodelling. Only
patients without LV remodelling showed correlation between infarct
size change and a change in LVEF (r=−0.43, p<0.005), b per cent
change in LVEDVI (r=0.27, p=0.05) and c per cent change in
LVESVI (r=0.41, p<0.005) (dashed line)
Table 2 Baseline and follow-up gated SPECT data for patients with
and without LV remodelling
With remodelling Without remodelling
(n=14) (n=54) p value
Infarct size (%)
Baseline 29.3±7.8 20.8±14.4 <0.04
Follow-up 25.0±11.1 14.0±11.5** <0.002
Infarct severity
Baseline 0.28±0.10 0.40±0.11 <0.001
Follow-up 0.30±0.12 0.45±0.13** <0.0001
LVEF (%)
Baseline 35.4±5.6 44.5±9.2 <0.001
Follow-up 34.9±7.6 47.5±10.0* <0.0001
LVEDVI (ml/m2)
Baseline 66.9±10.9 65.4±21.6 0.795
Follow-up 89.2±13.1** 60.8±23.9* <0.0001
LVESVI (ml/m2)
Baseline 43.3±8.9 37.6±18.8 0.273
Follow-up 58.8±14.4** 33.6±20.9* <0.0001
*p<0.05 and **p<0.001 versus 1-month value
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vascular stunning in the region of the infarction may persist
for weeks after restoration of blood flow [26] and the
gradual recovery of microvascular function may then result
in a delayed reduction of the perfusion defect size.
Furthermore, the myocardial infarction area may decrease
in the weeks after AMI due to oedema reabsorption and
phagocytation of dead myocardial cells and collagen
production and contraction [27]. We found a significant
relationship between late reduction in infarct size and
improvement in LV function. This finding might be
explained by the fact that a significant reduction in
perfusion defect is a prerequisite for LV function
recovery, and therefore represents a marker of positive
LV remodelling. However, we did not register a signif-
icant difference in infarct size reduction between patients
with and without LV remodelling. Therefore, we were
unable to confirm the cardiac magnetic resonance data
showing that patients with LV remodelling had substan-
tially larger infarct resorption compared with patients
without remodelling [8]. Conversely, our study demon-
strates that the reduction of infarct size beyond the
subacute phase may occur in all patients, in agreement
with prior scintigraphic reports [6, 24, 25]. This means
that infarct resorption could be a spontaneous event
occurring after AMI independently of its size and of the
patients’ outcome [26, 27]. Analysing separately patients
with and without LV remodelling, however, a significant
correlation between infarct resorption and LV functional
changes was observed only in the latter group. This
could imply a causative role of infarct resorption for LV
functional recovery.
On the other hand, the lack of correlation between infarct
resorption and functional evolution in patients with LV
remodelling suggests that other factors play a major role in
determining an unfavourable functional outcome. We ob-
served that infarct size and severity could be significant
predictors of LV remodelling. Several clinical studies demon-
strated that various parameters are predictive of remodelling,
including anterior infarct location, patency of the infarct-
related artery, perfusion and functional parameters [4–13]. In
agreement with these previous findings, the present study
showed a number of baseline parameters predictive of
remodelling, infarct severity demonstrating the best predic-
tive value. Our results are in disagreement with the studies
showing infarct size as the single significant predictor of LV
remodelling after AMI [5, 7], but are consistent with
previous studies demonstrating that the severity of the
infarction might be the best predictor of subsequent changes
in LV geometry and performance and is associated with LV
volume enlargement at follow-up [12, 13]. Because infarct
severity, assessed by SPECT, might be considered an
estimate of infarct transmurality, as demonstrated also by
several studies [28], our findings indirectly confirm that the
Fig. 3 Individual values of infarct resorption (defined as the defect
size difference between follow-up and baseline) in patients with and
without LV remodelling. Thick lines indicate mean values. The
difference between the two groups was not statistically significant
Fig. 2 Changes in perfusion and functional parameters over time in patients without (a) and with (b) LV remodelling. Thick lines represent
mean values
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presence of residual viability in the infarct territory could
favourably influence LV remodelling in long-term follow-up.
Indeed, the preservation of viable myocardium in the
subepicardium has been demonstrated to be a crucial
mechanism for maintaining LV shape and for preventing
infarct expansion [29].
According to our data, gated SPECT infarct size and
severity demonstrated a potential clinical utility in the
early identification of patients who will develop LV
remodelling at follow-up. Using the threshold values that
were identified by ROC curve analysis, in addition to
good sensitivity, specificity and accuracy, infarct size and
severity demonstrated a very strong negative predictive
value. In the subacute phase of reperfused AMI, this is a
major issue regarding the good prognosis and the benign
clinical course of these patients [3]. Identification of low-
risk patients allows focusing the attention on higher-risk
patients who would need a more aggressive therapy and
clinical follow-up. Interestingly, the infarct size threshold
that we found most effective was practically the same that
has been reported using cardiac magnetic resonance
imaging [8].
To the best of our knowledge, the present study is possibly
the first in which both myocardial perfusion and LV function
have been evaluated with gated SPECT 1 month after AMI as
well as at long-term follow-up, differently from most prior
reports in which functional data were derived from other
techniques, or gated SPECT data were collected over a short
time interval [5, 6, 12, 13]. 99mTc-Sestamibi gated SPECT
combines an accurate evaluation of both infarct size and
infarct severity with reliable measures of LV function and
volumes [30–33]. In addition, gated SPECT proved to be
accurate and robust in the evaluation of LV function,
compared to more established modalities [34], and also to
have a good reproducibility, even after a prolonged time
interval [35]. Another imaging technique capable of provid-
ing such double information is cardiac magnetic resonance
[7, 8]. Although this technique is more accurate in
visualizing AMI scars and measuring LV volumes than
gated SPECT, the latter technique still remains the most
easily and widely available method to perform stress
myocardial perfusion imaging and to detect inducible
ischaemia, with the additional advantage of permitting the
use of dynamic exercise as stressor. Therefore, in the follow-
up of patients already examined early after AMI, the
execution of stress-rest perfusion gated SPECT would allow
the comprehensive evaluation of both residual ischaemia and
LV functional evolution.
This study has some limitations that must be considered.
The patient population is relatively small and retrospec-
tively selected according to the availability of the gated
SPECT studies. In general, most of the studies dealing with
the issue of long-term functional evolution after reperfusion
therapy include a limited number of patients. Subjects with
a history of prior infarction as well as patients with
suboptimal PCI results were not considered; therefore, our
observations might not apply to those patients. Finally,
perfusion recovery at the follow-up study could be at least
in part a consequence of functional improvement, even if
there is evidence from previous reports that a delayed
perfusion recovery occurs in a significant number of
patients after PCI [6, 24, 25]. However, the decrease in
infarct size observed in patients with LV remodelling
suggests that functional improvement is not the sole
determinant of perfusion changes at follow-up.
Conclusion
The results of this study demonstrated a correlation
between perfusion parameters measured in the subacute
phase after AMI and change of functional parameters at
long-term follow-up. Infarct severity and infarct size
assessed using gated SPECT are able to predict LV
remodelling with clinically acceptable accuracy.
Fig. 4 Values of sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and accuracy of infarct size
(cutoff value 22.3%) and infarct severity (cutoff value 0.36) for the
prediction of LV remodelling
Table 3 Results of ROC curve analysis for the selection of the best
cutoff value of gated SPECT parameters for the prediction of LV
remodelling
Variable Best cutoff
value
Area under
the curve
Sensitivity
(%)
Specificity
(%)
Infarct size >22.3% 0.726 93 67
Infarct severity <0.36 0.775 86 67
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